期刊文献+

关于头孢米诺使用的研究分析 被引量:1

The Research and Analysis about the Use of Cefminox
下载PDF
导出
摘要 目的研究头孢米诺的药性以及使用方法,加强这种药物的临床推广。方法研究头孢米诺的药理、药动学以及用法等方面的知识,分析其在使用中容易产生的不良反应,避免患者在使用中出现过敏等症状。随机抽取我院头孢米诺使用患者的病历270份,填写"不良反应类型及临床表现调查表"。结果头孢米诺应用于注射,皮肤消化道不良反应发生率高和老年患者不良反应发生率高,应注意用法用量。结论在使用前,要对患者进行过敏反应实验,并在使用中注意观察患者反映,保障药物使用安全。 Objective Research the effects of the medicine and the method of the use of Cefminox to enhance the drug's clinical practice. Methods Research Cefminox's pharmacology, pharmacokinetics and other aspects of knowledge in use, analyze its foremost adverse reactions, avoid patients' allergy symptoms appearing. Randomly selected 270 patient records which use Cefminox for treatment, fill out the adverse reaction types and clinical manifestations survey. Results Cefminox used by injection, the incidence of adverse reactions about skin, gastrointestinal and elder patients is high. So we should note its dosage. Conclusion Allergy test of Cefminox is essential before use. Carefully observe the patients' reflections to ensure safety.
作者 王华 徐彬滨
出处 《中国医药指南》 2014年第18期50-51,共2页 Guide of China Medicine
关键词 头孢米诺 用法用量 不良反应 Cefminox Dosage Adverse reactions
  • 引文网络
  • 相关文献

参考文献3

二级参考文献25

  • 1朱德妹,吴湜,吴培澄,胡付品,叶信予,吴卫红,郭燕,张婴元.头孢美唑对产ESBLs肠杆菌科细菌的体外抗菌作用研究[J].中国感染与化疗杂志,2009,9(1):1-9. 被引量:11
  • 2李小荣.头孢米诺钠致神经系统不良反应1例[J].中国药物应用与监测,2006,3(1). 被引量:6
  • 3Clinical and Laboratory Standards Institute. Method for Dilution Antimicrobial Susceptibility Tests for Bacteria That Glow Aerobically[S]. Approved Standard -Eighth Edition, 2009, M07-A8.
  • 4Clinical and Laboratory Standards Institute. Method for Antimicrobial Susceptibility Tests for Anaerobic Bacteria[S]. Approved Standard -Seventh Edition, 2007, M11-A7.
  • 5Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing[S]. Twenty-second Informational Supplement, 2012, M100-S22.
  • 6Jones RN, Barry AL, Packer RR, et al. In vitro antimicrobial spectrum,occurrence of synergy, and recommendations for dilution susceptibility testing concentration of the eefopera zone-sulbactam combination [J]. J Clin Microbiol, 1987,25 (9): 1725-1729.
  • 7Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing[S]. Twentieth Informational Supplement, 2010, M100-S20.
  • 8Perez Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta lactamase genes in clinical isolates Byusing multiplex PCR[J]. J Clin Microbiol,2002, 40(6):2153-2162.
  • 9Tsuruoka T, Yamada Y, Goi H, et al. The bacteriolytic action of MT 141, a new cephamycin antibiotic, on gram-negative bacteria[J]. J Antimicrob Chemother, 1985,15(2) : 159-171.
  • 10Jones RN. Reviewof the in-vitro spectrum and characteristics of cefmetazole (CS-1170)[J]. J Antimicrob Chemother, 1989,23(Suppl D) :1-12.

共引文献23

同被引文献12

引证文献1

二级引证文献1

;
使用帮助 返回顶部